Real-world health status changes with mavacamten in symptomatic obstructive hypertrophic cardiomyopathy (oHCM) - Early findings from COMPASS-HCM
Conferences
Wang, A; Han, X; Zhong, Y; Schuler, P; Wang, Y; Yang, M; Martins, B; Spertus, JA
Published in: European Heart Journal
November 5, 2025
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
European Heart Journal
DOI
EISSN
1522-9645
ISSN
0195-668X
Publication Date
November 5, 2025
Volume
46
Issue
Supplement_1
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Wang, A., Han, X., Zhong, Y., Schuler, P., Wang, Y., Yang, M., … Spertus, J. A. (2025). Real-world health status changes with mavacamten in symptomatic obstructive hypertrophic cardiomyopathy (oHCM) - Early findings from COMPASS-HCM. In European Heart Journal (Vol. 46). Oxford University Press (OUP). https://doi.org/10.1093/eurheartj/ehaf784.4248
Wang, A., X. Han, Y. Zhong, P. Schuler, Y. Wang, M. Yang, B. Martins, and J. A. Spertus. “Real-world health status changes with mavacamten in symptomatic obstructive hypertrophic cardiomyopathy (oHCM) - Early findings from COMPASS-HCM.” In European Heart Journal, Vol. 46. Oxford University Press (OUP), 2025. https://doi.org/10.1093/eurheartj/ehaf784.4248.
Wang A, Han X, Zhong Y, Schuler P, Wang Y, Yang M, et al. Real-world health status changes with mavacamten in symptomatic obstructive hypertrophic cardiomyopathy (oHCM) - Early findings from COMPASS-HCM. In: European Heart Journal. Oxford University Press (OUP); 2025.
Wang, A., et al. “Real-world health status changes with mavacamten in symptomatic obstructive hypertrophic cardiomyopathy (oHCM) - Early findings from COMPASS-HCM.” European Heart Journal, vol. 46, no. Supplement_1, Oxford University Press (OUP), 2025. Crossref, doi:10.1093/eurheartj/ehaf784.4248.
Wang A, Han X, Zhong Y, Schuler P, Wang Y, Yang M, Martins B, Spertus JA. Real-world health status changes with mavacamten in symptomatic obstructive hypertrophic cardiomyopathy (oHCM) - Early findings from COMPASS-HCM. European Heart Journal. Oxford University Press (OUP); 2025.
Published In
European Heart Journal
DOI
EISSN
1522-9645
ISSN
0195-668X
Publication Date
November 5, 2025
Volume
46
Issue
Supplement_1
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology